Cerebrovascular P-glycoprotein expression is decreased in Creutzfeldt–Jakob disease
- 7 March 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Acta Neuropathologica
- Vol. 111 (5), 436-443
- https://doi.org/10.1007/s00401-006-0042-3
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- P-glycoprotein deficiency at the blood-brain barrier increases amyloid- deposition in an Alzheimer disease mouse modelJCI Insight, 2005
- Cytoplasmic domains of the transporter associated with antigen processing and P-glycoprotein interact with subunits of the proteasomeMolecular Immunology, 2005
- Games Played by Rogue Proteins in Prion Disorders and Alzheimer's DiseaseScience, 2003
- The Ubiquitin Proteasome System in Neurodegenerative Diseases: Sometimes the Chicken, Sometimes the EggNeuron, 2003
- Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseasesProceedings of the National Academy of Sciences of the United States of America, 2002
- Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjectsClinical Pharmacology & Therapeutics, 2001
- The spatial patterns of prion protein deposits in Creutzfeldt–Jakob disease: comparison with β-amyloid deposits in Alzheimer's diseaseNeuroscience Letters, 2001
- The Effect of Rifampin Treatment on Intestinal Expression of Human MRP TransportersThe American Journal of Pathology, 2000
- Decreased β-amyloid 1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob diseaseNeurology, 2000
- Conformational diseaseThe Lancet, 1997